Flomerics Group PLC
11 June 2004
FLOMERICS GROUP PLC
11 JUNE 2004
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
FLOMERICS GROUP PLC
2) NAME OF DIRECTOR
DAVID TATCHELL
3) Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non-beneficial interest
IN RESPECT OF HOLDING OF THE DIRECTOR NAMED IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the number
of shares held by each of them (if notified)
DAVID TATCHELL
5) Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s)
N/A
6) Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
GRANT OF OPTIONS
7) Date of grant
11 JUNE 2004
8) Period during which or date on which exercisable
11 JUNE 2007 to 10 JUNE 2014
9) Total amount paid (if any) for grant of the option
NIL COST OPTIONS
10) Description of shares or debentures involved: class, number
80,000 1P ORDINARY SHARES
11) Exercise price (if fixed at time of grant) or indication that grant is
to be fixed at time of exercise
61.5P
12) Total number of shares held and total number of shares or debentures over
which options held following this notification
101,250 1P ORDINARY SHARES
13) Any additional information
N/A
14) Name of contact and telephone number for queries
CHRISTOPHER HARDIE, TEATHER & GREENWOOD
15) Name and signature of authorised company official responsible for making
this notification
CHRIS OGLE, FLOMERICS GROUP PLC
Date of notification
11 JUNE 2004
END
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
FLOMERICS GROUP PLC
2) NAME OF DIRECTOR
CHRIS OGLE
3) Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non-beneficial interest
IN RESPECT OF HOLDING OF THE DIRECTOR NAMED IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the number
of shares held by each of them (if notified)
CHRIS OGLE
5) Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s)
N/A
6) Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
GRANT OF OPTIONS
7) Date of grant
11 JUNE 2004
8) Period during which or date on which exercisable
11 JUNE 2007 to 10 JUNE 2014
9) Total amount paid (if any) for grant of the option
NIL COST OPTIONS
10) Description of shares or debentures involved: class, number
45,000 1P ORDINARY SHARES
11) Exercise price (if fixed at time of grant) or indication that grant is
to be fixed at time of exercise
61.5P
12) Total number of shares held and total number of shares or debentures over
which options held following this notification
166,250 1P ORDINARY SHARES
13) Any additional information
N/A
14) Name of contact and telephone number for queries
CHRISTOPHER HARDIE, TEATHER & GREENWOOD
15) Name and signature of authorised company official responsible for making
this notification
CHRIS OGLE, FLOMERICS GROUP PLC
Date of notification
11 JUNE 2004
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.